Jefferies analyst Brian Tanquilut raised the firm’s price target on RadNet to $80 from $75 and keeps a Buy rating on the shares. RadNet has delivered seven consecutive quarters of EBITDA beats, driven by continued top line strength in its core diagnostic center imaging business, whose secular tailwinds persist, the analyst tells investors. The upcoming rollout of DeepHealth OS should drive margin upside in FY25, while the firm sees upcoming AI catalysts that “should push the stock higher,” the analyst added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RDNT:
- RadNet, Inc. to Present at the Sidoti & Company Small Cap 2024 Virtual Conference on Wednesday, September 18th
- RadNet Names Kees Wesdorp as Digital Health Division CEO
- RadNet, Inc. Announces the Appointment of Kees Wesdorp as President and Chief Executive Officer of RadNet’s Digital Health Division
- QuidelOrtho appoints Lee Bowman as chief human resources officer
- Broadcom AI results fail to enthuse the Street: Morning Buzz